Redeye: Opus Group - Excellent results in Sweden

The overall outcome of the Q3 report was better than expected. It was the Swedish business that surprised quite positively this time, in terms of both revenue and profit. US & Asia remains stable and shows even better profitability, while the smaller IVS and Latin America units still have some way to go. (This is an English version of our Q3-update published earlier on November 18)

Read more and download the research update: http://bit.ly/35gm6o6

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/